|
Index of reports
> Cases with Dyspnoea (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Glucagon where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Glucagon side effects in female
Reported by a physician from United States on 2012-03-08
Patient: female
Reactions: Cellulitis, Dyspnoea, Nausea, Skin Ulcer, International Normalised Ratio Increased, Pulmonary Oedema, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Saxagliptin
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-23
Insulin Lispro
Dosage: 10 iu, unk
Indication: Type 2 Diabetes Mellitus
Placebo
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Insulin Glargine
Dosage: 35 iu, unk
Indication: Type 2 Diabetes Mellitus
Glucagon
Dosage: 1 mg, unk
Indication: Type 2 Diabetes Mellitus
Metformin HCL
Dosage: 2000 mg, unk
Start date: 2010-08-23
Other drugs received by patient possibly interacting with the suspect drug:
Coumadin
Dosage: unk
Septra
Dosage: 1600 mg, unk
Administration route: Oral
Start date: 2010-12-05
End date: 2010-12-11
Other drugs received by patient: Aspirin
Possible Glucagon side effects in female
Reported by a physician from United States on 2012-03-01
Patient: female
Reactions: Cellulitis, Dyspnoea, Skin Ulcer, International Normalised Ratio Increased, Drug Interaction, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metformin HCL
Dosage: 2000 mg, unk
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-23
Placebo
Dosage: unk mg, unk
Indication: Type 2 Diabetes Mellitus
Insulin Glargine
Dosage: 35 iu, unk
Indication: Type 2 Diabetes Mellitus
Saxagliptin
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-23
Glucagon
Dosage: 1 mg, unk
Indication: Type 2 Diabetes Mellitus
Insulin Lispro
Dosage: 10 iu, unk
Indication: Type 2 Diabetes Mellitus
Other drugs received by patient possibly interacting with the suspect drug:
Septra
Dosage: 1600 mg, unk
Administration route: Oral
Start date: 2010-12-05
End date: 2010-12-11
Warfarin Sodium
Other drugs received by patient: Aspirin
Possible Glucagon side effects in female
Reported by a physician from United States on 2012-02-24
Patient: female
Reactions: Dyspnoea, Cellulitis, Nausea, Skin Ulcer, International Normalised Ratio Increased, Drug Interaction, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metformin HCL
Dosage: 2000 mg, unk
Start date: 2010-08-23
Insulin Glargine
Dosage: 35 iu, unk
Indication: Type 2 Diabetes Mellitus
Placebo
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Glucagon
Dosage: 1 mg, unk
Indication: Type 2 Diabetes Mellitus
Saxagliptin
Dosage: unk
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-23
Insulin Lispro
Dosage: 10 iu, unk
Indication: Type 2 Diabetes Mellitus
Other drugs received by patient possibly interacting with the suspect drug:
Septra
Dosage: 1600 mg, unk
Administration route: Oral
Start date: 2010-12-05
End date: 2010-12-11
Coumadin
Dosage: unk
Other drugs received by patient: Aspirin
Possible Glucagon side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-09
Patient: female
Reactions: Dyspnoea, Asthenia, Mobility Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glucagon
Dosage: unk, prn
Glucagon
Dosage: unk, prn
Indication: Hypoglycaemia
Start date: 2000-03-01
Other drugs received by patient: Methotrexate; Dextrose
|
